Osaic Holdings
FDMT icon

Osaic Holdings’s 4D Molecular Therapeutics FDMT Stock Holding History

Osaic Holdings’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466 Sell
35
-18
-34% -$175 ﹤0.01% 7664
2026
Q1 		$493 Buy
53
+31
+141% +$270 ﹤0.01% 7442
2025
Q4 		$165 Buy
22
+17
+340% +$172 ﹤0.01% 7598
2025
Q3 		$43 Sell
5
-5
-50% -$30 ﹤0.01% 7791
2025
Q2 		$38 Buy
10
+5
+100% +$18 ﹤0.01% 7630
2025
Q1 		$16 Sell
5
-63
-93% -$297 ﹤0.01% 7359
2024
Q4 		$379 Sell
68
-17,609
-100% -$138K ﹤0.01% 7074
2024
Q3 		$191K Buy
17,677
+17,542
+12,994% +$291K ﹤0.01% 3680
2024
Q2 		$2.83K Buy
+135
New +$3.39K ﹤0.01% 6458
2024
Q1 		– Sell
-1,575
Closed -$31.9K – 7260
2023
Q4 		$31.9K Hold
1,575
– – ﹤0.01% 5196
2023
Q3 		$20.1K Hold
1,575
– – ﹤0.01% 5553
2023
Q2 		$28.5K Sell
1,575
-211
-12% -$3.88K ﹤0.01% 5326
2023
Q1 		$30.7K Buy
1,786
+87
+5% +$1.69K ﹤0.01% 5304
2022
Q4 		$38K Sell
1,699
-4,020
-70% -$62.1K ﹤0.01% 5131
2022
Q3 		$46K Hold
5,719
– – ﹤0.01% 4974
2022
Q2 		$40K Hold
5,719
– – ﹤0.01% 5117
2022
Q1 		$86K Sell
5,719
-167
-3% -$2.62K ﹤0.01% 4701
2021
Q4 		$129K Buy
5,886
+11
+0.2% +$270 ﹤0.01% 4349
2021
Q3 		$158K Hold
5,875
– – ﹤0.01% 4114
2021
Q2 		$141K Buy
+5,875
New +$180K ﹤0.01% 4190

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Osaic Holdings's FDMT Position: Q2 2026 in Review

Osaic Holdings reduced its 4D Molecular Therapeutics (FDMT) stake by 34% in Q2 2026, selling an estimated $175 and leaving 35 shares worth $466. The position accounts for ﹤0.01% of the portfolio, ranked #7664.

Osaic Holdings first reported a position in FDMT in Q2 2021 and has held it in 20 quarters since. The position peaked at $191K in Q3 2024. 157 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • Osaic Holdings held 35 shares of 4D Molecular Therapeutics worth $466 as of Q2 2026.
  • Osaic Holdings sold 18 4D Molecular Therapeutics shares in Q2 2026, an estimated $175.
  • 4D Molecular Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7664 holding.
  • Osaic Holdings first reported a position in 4D Molecular Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Osaic Holdings's 4D Molecular Therapeutics position peaked at $191K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.